Biotech

Miraculins Announces Closing of Private Placement Offering

WINNIPEG, MANITOBA: ...

Ceapro''s Research Scientist, Bernhard Seifried, Ph.D., Honored with Scientific Achievement & Innovation Award from BioAlberta

EDMONTON, ALBERTA: Ceapro's PGX Technology enables production of pharmaceutical grade Beta Glucan ...

Critical Outcome Technologies Completes Private Placement

LONDON, ONTARIO: Funding better positions the Company and COTI-2 for Phase 1 Clinical study ...

Atossa Genetics to Present at Upcoming Investor Conferences and Events in December, 2014

SEATTLE, WA: ...

ScripsAmerica Highlights CEO Interviews From Recent Investor Conference

TYSONS CORNER, VA: ...

Immunovaccine Receives Final Approval to Graduate to TSX

HALIFAX, NOVA SCOTIA: Shares to Begin Trading on TSX at Opening of Market on November 26 ...

Boston Therapeutics and Advance Pharmaceutical Expand Agreement to Market sugardown(R) in 12 Additional Countries in Asia

MANCHESTER, NH: Agreement Expands Number of Asian Countries Where sugardown(R) Can Be Marketed From 3 to 15; Boston Therapeutics Receives Purchase Order for 60,000 Units ...

Ceapro Appoints World Renowned Health and Disease Management Expert, William W. Li, M.D. to Board of Directors

EDMONTON, ALBERTA: ...

Titan Pharmaceuticals Announces Completion of Enrollment in Phase 3 Study of Probuphine for Opioid Dependence

SOUTH SAN FRANCISCO, CA: Braeburn Expands Portfolio for Opioid Addiction Treatment, Potentially Adding up to $50 Million to Future Titan Royalties ...

Kadmon Corporation Presents Preclinical Data on Bi-Functional Anti-PD-L1/IL-15 Fusion Protein at EORTC-NCI-AACR Symposium

NEW YORK, NY: Novel Immuno-Oncology Approach With Potential for Enhanced Antitumor Effect ...